Free News Archives
Latest Issue of OR Manager
May 2024

New inhaled vaccine delivers broad protection against COVID-19, variants

Editor's Note In this study, Canadian researchers at McMaster University (Hamilton, Ontario) confirm that their newly developed inhaled form of COVID-19 vaccine provides long-lasting protection against the original strain of SARS-Cov-2 and variants of concern. The researchers compared two types of adenovirus platforms for the vaccine. The adenoviruses serve as…

Read More

By: Judy Mathias
February 10, 2022
Share

Amazon expands telehealth services

Editor's Note Amazon announced on February 8 that it is expanding its telehealth service, Amazon Care, nationwide. Previously, it was available only to employees and their families in and around its Seattle headquarters. Amazon also is expanding its in-person care services to more than 20 new cities this year. When…

Read More

By: Judy Mathias
February 10, 2022
Share

HHS to give $66.5 million towards community-based outreach to boost COVID-19 vaccination rates

Editor's Note According to the February 10 Healthcare Purchasing News, the US Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a new American Rescue Plan funding of $66.5 million to help expand outreach efforts to boost COVID-19 vaccine rates. The funding will…

Read More

By: Tarsilla Moura
February 10, 2022
Share

Vaccine effectiveness against COVID-19 during 9 months after second vaccination

Editor's Note This study by researchers at Umea University in Sweden finds a progressive waning in vaccine effectiveness against COVID-19 of any severity during the first 9 months after the second vaccination, with the rate of waning differing by vaccine type Analyzing the total population of Sweden, vaccine effectiveness was…

Read More

By: Judy Mathias
February 8, 2022
Share

FDA: Class I recall of Empowered Diagnostics COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on January 28 identified the recall by Empowered Diagnostics (Pompano Beach, Florida) of its CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test as Class I, the most serious. Empowered Diagnostics distributed these tests with labeling indicating they were…

Read More

By: Judy Mathias
February 8, 2022
Share

4,900+ healthcare job cuts in January linked to vaccine refusal

Editor's Note In January, 5,757 workers lost their employment because they refused to get vaccinated against COVID-19 as ordered by a federal mandate and various local mandates covering private businesses. Out of those workers, 4,934 were healthcare providers, the February 4 Becker’s Hospital Review reports from data gathered by executive…

Read More

By: Tarsilla Moura
February 8, 2022
Share

CDC: Early evidence of Omicron in community wastewater

Editor's Note This study by researchers from the Centers for Disease Control and Prevention (CDC) finds that wastewater surveillance programs in four states were the first to detect evidence of Omicron in community wastewater. California: Omicron was detected in samples collected November 25 and 30, 2021, in two Northern communities.…

Read More

By: Judy Mathias
February 8, 2022
Share

CDC adds wastewater surveillance to COVID-19 dashboard

Editor's Note The Centers for Disease Control and Prevention (CDC) on February 4 announced that it is adding wastewater surveillance to its COVID-19 dashboard data tracking system. The CDC will track the spread of COVID-19 variants based on measurements at more than 500 wastewater monitoring sites across the US. This…

Read More

By: Judy Mathias
February 8, 2022
Share

Study: Risk of catching COVID-19 during hospital stay remains low

Editor's Note A new Cosmos study by Epic Research finds that cases of “hospital-developed COVID-19”—or patients who were admitted to the hospital free of infection but acquired COVID-19 during their hospital stay—are low, the American Hospital Association reported February 7. According to the study, only about 1.8% of patients admitted…

Read More

By: Tarsilla Moura
February 8, 2022
Share

Prevalence, durability of COVID-19 antibodies in unvaccinated

Editor's Note This study led by Marty Makary, MD, MPH, and Dorry Segev, MD, PhD, at Johns Hopkins University School of Medicine, Baltimore, finds natural immunity in unvaccinated healthy US adults up to 20 months after testing positive for COVID-19. Of 1,580 study participants, antibodies were detected in: 99% of…

Read More

By: Judy Mathias
February 7, 2022
Share
Live chat by BoldChat